US 12,391,708 B2
Crystalline Lorlatinib : fumaric acid and solid state form thereof
Lorena Kordic, Rab (HR); Ivica Grebenar, Zagreb (HR); and Dijana Škalec Šamec, Jastrebarsko (HR)
Assigned to TAPI CROATIA INDUSTRIES LTD, Prigorje Brdovecko (HR)
Appl. No. 17/624,870
Filed by TAPI CROATIA INDUSTRIES LTD, Prigorje Brdovecko (HR)
PCT Filed Jul. 10, 2020, PCT No. PCT/US2020/041524
§ 371(c)(1), (2) Date Jan. 5, 2022,
PCT Pub. No. WO2021/011345, PCT Pub. Date Jan. 21, 2021.
Claims priority of provisional application 62/875,601, filed on Jul. 18, 2019.
Prior Publication US 2022/0289764 A1, Sep. 15, 2022
Int. Cl. C07D 498/18 (2006.01)
CPC C07D 498/18 (2013.01) [C07B 2200/13 (2013.01)] 16 Claims
 
1. Anhydrous Crystalline Lorlatinib:Fumaric acid which is a co-crystal.